ATE441419T1 - Verwendung von loteprednoletabonat zur behanldung von trockenen augen - Google Patents

Verwendung von loteprednoletabonat zur behanldung von trockenen augen

Info

Publication number
ATE441419T1
ATE441419T1 AT05729286T AT05729286T ATE441419T1 AT E441419 T1 ATE441419 T1 AT E441419T1 AT 05729286 T AT05729286 T AT 05729286T AT 05729286 T AT05729286 T AT 05729286T AT E441419 T1 ATE441419 T1 AT E441419T1
Authority
AT
Austria
Prior art keywords
tabonate
loteprednole
dry eyes
treat dry
patient
Prior art date
Application number
AT05729286T
Other languages
English (en)
Inventor
Stephen Bartels
Original Assignee
Bausch & Lomb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34963566&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE441419(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bausch & Lomb filed Critical Bausch & Lomb
Application granted granted Critical
Publication of ATE441419T1 publication Critical patent/ATE441419T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
AT05729286T 2004-03-25 2005-03-24 Verwendung von loteprednoletabonat zur behanldung von trockenen augen ATE441419T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55616104P 2004-03-25 2004-03-25
PCT/US2005/009761 WO2005094836A2 (en) 2004-03-25 2005-03-24 Use of loteprednol etabonate for the treatment of dry eye

Publications (1)

Publication Number Publication Date
ATE441419T1 true ATE441419T1 (de) 2009-09-15

Family

ID=34963566

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05729286T ATE441419T1 (de) 2004-03-25 2005-03-24 Verwendung von loteprednoletabonat zur behanldung von trockenen augen

Country Status (14)

Country Link
US (1) US20050222110A1 (de)
EP (2) EP2127655A1 (de)
JP (1) JP2007530573A (de)
KR (1) KR20070004750A (de)
CN (1) CN1964719B (de)
AT (1) ATE441419T1 (de)
AU (1) AU2005229006B9 (de)
BR (1) BRPI0509220A (de)
CA (1) CA2560824A1 (de)
DE (1) DE602005016392D1 (de)
ES (1) ES2330762T3 (de)
MX (1) MXPA06010849A (de)
TW (1) TW200602030A (de)
WO (1) WO2005094836A2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7691811B2 (en) * 2006-05-25 2010-04-06 Bodor Nicholas S Transporter-enhanced corticosteroid activity and methods and compositions for treating dry eye
CN101317847B (zh) * 2007-06-06 2010-10-13 深圳市瑞谷医药技术有限公司 一种眼用或耳鼻用药物组合物及其用途
US20090239836A1 (en) * 2008-03-24 2009-09-24 Mary Lee Ciolkowski Multifunctional Ophthalmic Compositions
US8835410B2 (en) 2011-05-10 2014-09-16 Bodor Laboratories, Inc. Treatment of eyelid dermatitis
WO2013133980A1 (en) * 2012-03-05 2013-09-12 Bausch & Lomb Incorporated Nitroxy derivatives of soft steroids
US9827191B2 (en) 2012-05-03 2017-11-28 The Johns Hopkins University Compositions and methods for ophthalmic and/or other applications
ES3055223T3 (en) 2012-05-03 2026-02-10 Alcon Inc Pharmaceutical nanoparticles showing improved mucosal transport
US11596599B2 (en) 2012-05-03 2023-03-07 The Johns Hopkins University Compositions and methods for ophthalmic and/or other applications
JP6360039B2 (ja) 2012-05-03 2018-07-18 カラ ファーマシューティカルズ インコーポレイテッド 複数の被覆された粒子を含む組成物、医薬組成物、医薬製剤、及び当該粒子の形成方法
EP2956138B1 (de) 2013-02-15 2022-06-22 Kala Pharmaceuticals, Inc. Therapeutische verbindungen und verwendungen davon
US9688688B2 (en) 2013-02-20 2017-06-27 Kala Pharmaceuticals, Inc. Crystalline forms of 4-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinazolin-7-yl)oxy)-1-(2-oxa-7-azaspiro[3.5]nonan-7-yl)butan-1-one and uses thereof
MX368903B (es) 2013-02-20 2019-10-21 Kala Pharmaceuticals Inc Compuestos terapéuticos y sus usos en el tratamiento de enfermedades proliferativas.
US9890173B2 (en) 2013-11-01 2018-02-13 Kala Pharmaceuticals, Inc. Crystalline forms of therapeutic compounds and uses thereof
US9458169B2 (en) 2013-11-01 2016-10-04 Kala Pharmaceuticals, Inc. Crystalline forms of therapeutic compounds and uses thereof
CN106279325A (zh) * 2015-05-27 2017-01-04 天津金耀集团有限公司 一种依碳氯替泼诺新晶型及其制备方法
CN106279324A (zh) * 2015-05-27 2017-01-04 天津金耀集团有限公司 依碳氯替泼诺一水合物及其晶型与制备方法
CN106892952A (zh) * 2015-12-21 2017-06-27 天津金耀集团有限公司 一种依碳氯替泼诺新晶型及其制备方法
CN106892953A (zh) * 2015-12-21 2017-06-27 天津金耀集团有限公司 依碳氯替泼诺一水合物及其晶型与制备方法
EP3509423A4 (de) 2016-09-08 2020-05-13 Kala Pharmaceuticals, Inc. Kristalline formen von therapeutischen verbindungen und verwendungen davon
AU2017324713B2 (en) 2016-09-08 2020-08-13 KALA BIO, Inc. Crystalline forms of therapeutic compounds and uses thereof
US10336767B2 (en) 2016-09-08 2019-07-02 Kala Pharmaceuticals, Inc. Crystalline forms of therapeutic compounds and uses thereof
WO2018212846A1 (en) * 2017-05-19 2018-11-22 Ocugen, Inc. Ophthalmic compositions and methods of use

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US104A (en) 1836-12-10 Revolving hokse-rake
US5075A (en) 1847-04-17 Improvement in cultivators
US4710495A (en) 1980-07-10 1987-12-01 Otsuka Pharmaceutical Co., Ltd. Soft steroids having anti-inflammatory activity
US4996335A (en) 1980-07-10 1991-02-26 Nicholas S. Bodor Soft steroids having anti-inflammatory activity
US6610675B1 (en) 1980-07-10 2003-08-26 Nicholas S. Bodor Inactive metabolite approach to soft drug design
US4883658A (en) 1986-04-28 1989-11-28 Holly Frank J Ophthalmic solution for treatment of dry-eye syndrome
US4804539A (en) 1986-07-28 1989-02-14 Liposome Technology, Inc. Ophthalmic liposomes
US4914088A (en) 1987-04-02 1990-04-03 Thomas Glonek Dry eye treatment solution and method
US5278151A (en) 1987-04-02 1994-01-11 Ocular Research Of Boston, Inc. Dry eye treatment solution
ZA912797B (en) 1990-05-29 1992-12-30 Boston Ocular Res Dry eye treatment process and solution
EP0459148B1 (de) 1990-05-29 1996-01-03 Ocular Research Of Boston Inc. Zusammensetzung zur Behandlung von Dry Eye Erkrankungen
ZA927277B (en) 1991-10-02 1993-05-19 Boston Ocular Res Dry eye treatment process and solution.
US5540930A (en) 1993-10-25 1996-07-30 Pharmos Corporation Suspension of loteprednol etabonate for ear, eye, or nose treatment
WO1997020578A1 (en) 1995-12-04 1997-06-12 University Of Miami Non-preserved topical corticosteroid for treatment of dry eye, filamentary keratitis, and delayed tear clearance
US6096052A (en) * 1998-07-08 2000-08-01 Ovion, Inc. Occluding device and method of use
US7073504B2 (en) * 1996-12-18 2006-07-11 Ams Research Corporation Contraceptive system and method of use
TW503113B (en) 1997-01-16 2002-09-21 Senju Pharma Co Aqueous suspension for nasal administration
KR100508227B1 (ko) 1997-03-14 2006-03-23 센주 세이야꾸 가부시키가이샤 로테프레드놀에타보네이트수성현탁액
DE19947234A1 (de) * 1999-09-30 2001-04-05 Asta Medica Ag Neue Kombination von Loteprednol und Antihistaminika
EP1392322A1 (de) 2001-05-21 2004-03-03 Alcon, Inc. Methode zur behandlung des trockenen auges
PL369960A1 (en) * 2001-10-11 2005-05-02 Alcon, Inc. Methods for treating dry eye by a combination of an antiinflammatory steroid and a muc-1 secretagogue
MXPA04008171A (es) * 2002-02-22 2004-11-26 Pharmacia Corp Formulacion oftalmica con sistema de goma.
US7074426B2 (en) * 2002-03-27 2006-07-11 Frank Kochinke Methods and drug delivery systems for the treatment of orofacial diseases
AU2003301129A1 (en) * 2002-12-20 2004-07-22 Control Delivery Systems, Inc. Steroid compositions for intraocular use
WO2004073748A1 (ja) * 2003-02-20 2004-09-02 Senju Pharmaceutical Co., Ltd. 水性懸濁液剤
US20050182039A1 (en) * 2004-02-13 2005-08-18 Bausch & Lomb Incorporated Use of Loteprednol etabonate for the treatment of dry eye

Also Published As

Publication number Publication date
WO2005094836A3 (en) 2006-01-26
TW200602030A (en) 2006-01-16
AU2005229006B2 (en) 2011-01-20
HK1102551A1 (en) 2007-11-30
CN1964719A (zh) 2007-05-16
EP1744759A2 (de) 2007-01-24
EP2127655A1 (de) 2009-12-02
DE602005016392D1 (de) 2009-10-15
US20050222110A1 (en) 2005-10-06
KR20070004750A (ko) 2007-01-09
CA2560824A1 (en) 2005-10-13
BRPI0509220A (pt) 2007-09-04
JP2007530573A (ja) 2007-11-01
EP1744759B1 (de) 2009-09-02
WO2005094836A2 (en) 2005-10-13
AU2005229006A1 (en) 2005-10-13
MXPA06010849A (es) 2007-03-08
AU2005229006B9 (en) 2011-05-19
CN1964719B (zh) 2010-05-05
ES2330762T3 (es) 2009-12-15

Similar Documents

Publication Publication Date Title
ATE441419T1 (de) Verwendung von loteprednoletabonat zur behanldung von trockenen augen
EA200801717A1 (ru) Композиция местного применения по уходу за кожей, продукт на ее основе и способ лечения
DE60312309D1 (de) Verwendung von botulinum toxin zur behandlung von herz- und kreislaufskrankheiten
ATE551996T1 (de) Behandlung oder prävention von diabetes mit cannabidiol
EA200501897A2 (ru) Ручное устройство и способ светолечения
HRP20120887T1 (en) Adherent cells from adipose or placenta tissues and use thereof in therapy
WO2007089454A3 (en) Methods for enhancing skin treatments
ATE475414T1 (de) Tuberkulosebehandlung mit pleuromutilinderivaten
ATE509663T1 (de) Ballon-brachytherapie-applikator
ATE368455T1 (de) Verwendung von (+)-tramadol, o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz
DE69829202D1 (de) Verwendung von mirtazapine zur herstellung eines medikaments zur behandlung von schlafapnoen
ATE380554T1 (de) Verwendung von xenon mit hypothermie zur behandlung von neugeborenen-asphyxie
ATE447426T1 (de) Elektromagnetische stimulation bei patienten mit osteoporose
CN108785843A (zh) 一种美容方法
DK1732551T3 (da) Perhexilin til behandling af kronisk hjertesvigt
DE60020111D1 (de) Therapeutische anwendung von cannabinoiden zur hirntumorbehandlung
ATE448779T1 (de) Methode zur behandlung trockener augen und uveitis
DE60216292D1 (de) Calciumtrifluoracetat mit zytotoxischer wirkung
ATE367823T1 (de) E-selectin zur behandlung oder vorbeugung von schlaganfall
EP1495755B8 (de) Verwendung von Citrullin zur Herstellung eines Arzneimittels zur Behandlung von ans Altern oder an eine Bestrahlung gebundener intestinaler Insuffizienz
CN201906075U (zh) 一种眼罩
ATE359088T1 (de) Verwendung von interleukin-18 zur behandlung von uv-assoziierten hautkrankheiten
CN209679297U (zh) 一种石英表式激光电子脉冲治疗仪
TW200509922A (en) Methods of therapeutic treatment using amounts of retinoid components
RU2009100338A (ru) Способ лечения гипербилирубинемии новорожденных

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties